EverSource Wealth Advisors’s Alaunos Therapeutics TCRT Stock Holding History

EverSource Wealth Advisors’s Portfolio TCRT Stock Details TCRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$120	Buy	+135	New	+$237	﹤0.01%	4379
2024 Q1	–	Hold	0	–	-$3	–	2990
2023 Q4	–	Hold	0	–	–	–	2631
2023 Q3	–	Hold	0	–	–	–	2488
2023 Q2	–	Hold	0	–	–	–	2476
2023 Q1	–	Hold	0	–	–	–	2366
2022 Q4	–	Hold	0	–	–	–	2291

Other funds holding TCRT

BOK Financial Tulsa, Oklahoma $6.69B AUM 26.84% 1-Year Est. Return

Key Financial Inc West Chester, Pennsylvania $614M AUM 14.43% 1-Year Est. Return

SignatureFD Atlanta, Georgia $7.76B AUM 16.09% 1-Year Est. Return

Newbridge Financial Services Group Boca Raton, Florida $868M AUM 42.47% 1-Year Est. Return

NBC Securities Birmingham, Alabama $1.47B AUM 20.38% 1-Year Est. Return

West Paces Advisors Atlanta, Georgia $586M AUM 14.12% 1-Year Est. Return

Inspire Investing Meridian, Idaho $2.37B AUM 29.82% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

EverSource Wealth Advisors's TCRT Position: Q3 2026 in Review

EverSource Wealth Advisors opened a new position in Alaunos Therapeutics (TCRT) in Q3 2026: 135 shares worth $120. The stake represents ﹤0.01% of the portfolio and ranks #4379 among its holdings.

9 funds tracked by Wall St. Rank hold TCRT as of Q3 2026.

EverSource Wealth Advisors held 135 shares of Alaunos Therapeutics worth $120 as of Q3 2026.
Alaunos Therapeutics was a new EverSource Wealth Advisors position in Q3 2026.
Alaunos Therapeutics made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q3 2026, its #4379 holding.
9 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q3 2026.

Based on EverSource Wealth Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.